Leukocyte Imbalances in Mucopolysaccharidoses Patients
Authors:
- Nuno LopesNLNuno Lopes
- Maria LuzMLMaria Luz
- Catia PereiraCPCatia Pereira
- Inês Mondragão-RodriguesIMInês Mondragão-Rodrigues
- Esmeralda MartinsEMEsmeralda Martins
- Rosa RibeiroRRRosa Ribeiro
- Ana GasparAGAna Gaspar
- Patrício AguiarPAPatrício Aguiar
- Paula GarciaPGPaula Garcia
- Maria Teresa CardosoMCMaria Teresa Cardoso
- Esmeralda RodriguesEREsmeralda Rodrigues
- Elisa Leão-TelesELElisa Leão-Teles
Preprint
- 30 May 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Mucopolysaccharidoses (MPSs) are rare inherited lysosomal storage diseases (LSDs) caused by deficient activity in one of the enzymes responsible for glycosaminoglycans lysosomal degradation. MPS II is caused by pathogenic mutations in the IDS gene, leading to deficient activity of the enzyme iduronate-2-sulfatase, which causes dermatan and heparan sulfate storage in the lysosomes. MPS VI has dermatan sulfate lysosomal storage, owing to a deficiency of arylsulfatase B, due to pathogenic mutations in the ARSB gene. Alterations in the immune system of MPSs mouse models have been described but the data is still scarce concerning MPSs patients. Herein, we study different leukocyte populations in MPS II and VI disease patients. MPS VI, but not MPS II patients, have a decrease percentage of Natural Killer (NK) cells and monocytes when compared with controls. No alterations were identified in the percentage of T, invariant NKT and B cells in both groups of MPS disease patients. However, we uncovered alterations in the naïve versus memory status of both helper and cytotoxic T cells in MPS VI disease patients compared to control group. Indeed, MPS VI disease patients have a higher frequency of naïve T cells and consequently lower frequency of memory T cells than control subjects. Altogether, these results reveal MPS VI disease-specific alterations in some leukocyte populations, suggesting that the type of substrate accumulated and/or enzyme deficient in the lysosome may have a particular effect on the normal cellular composition of the immune system.Keywords
All Related Versions
- Version 1, 2023-05-30, Preprints
- Published version: Biomedicines, 11 (6), 1699.
This publication has 52 references indexed in Scilit:
- Activated and Memory T Lymphocytes in Children with Gaucher DiseaseArchivum Immunologiae et Therapiae Experimentalis, 2016
- The impact of the immune system on the safety and efficiency of enzyme replacement therapy in lysosomal storage disordersJournal of Inherited Metabolic Disease, 2016
- Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunityJournal of Inherited Metabolic Disease, 2013
- Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I)Journal of Inherited Metabolic Disease, 2012
- Leukocyte perturbation associated with Fabry diseaseJournal of Inherited Metabolic Disease, 2009
- Glycosaminoglycans modulate inflammation and apoptosis in LPS‐treated chondrocytesJournal of Cellular Biochemistry, 2008
- Innate and adaptive immune activation in the brain of MPS IIIB mouse modelJournal of Neuroscience Research, 2008
- Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolismEuropean Journal of Immunology, 2007
- Immunodeficiency in alpha-mannosidosis: a matched case-control study on immunoglobulins, complement factors, receptor density, phagocytosis and intracellular killing in leucocytesEuropean Journal of Pediatrics, 2000
- The monocyte-macrophage system is affected in lysosomal storage diseases: an immunoelectron microscopic studyActa Neuropathologica, 1997